200 related articles for article (PubMed ID: 28422266)
1. Transient Elastography May Improve Detection of Liver Fibrosis in Psoriasis Patients Treated with Methotrexate.
Talme T; Nikamo P; Rosenberg P; Ståhle M
Acta Derm Venereol; 2017 Aug; 97(8):952-954. PubMed ID: 28422266
[No Abstract] [Full Text] [Related]
2. The use of transient elastography and FibroTest for monitoring hepatotoxicity in patients receiving methotrexate for psoriasis.
Lynch M; Higgins E; McCormick PA; Kirby B; Nolan N; Rogers S; Lally A; Vellinga A; Omar H; Collins P
JAMA Dermatol; 2014 Aug; 150(8):856-62. PubMed ID: 24964792
[TBL] [Abstract][Full Text] [Related]
3. Evaluation of liver fibrosis by transient elastography in methotrexate treated patients.
Barbero-Villares A; Mendoza J; Trapero-Marugan M; Gonzalez-Alvaro I; Daudén E; Gisbert JP; Moreno-Otero R
Med Clin (Barc); 2011 Nov; 137(14):637-9. PubMed ID: 21719043
[TBL] [Abstract][Full Text] [Related]
4. Diagnostic performance of transient elastography for detection of methotrexate-induced liver injury using Roenigk classification in Asian patients with psoriasis: a retrospective study.
Rongngern P; Chularojanamontri L; Wongpraparut C; Silpa-Archa N; Chotiyaputta W; Pongpaibul A; Charatcharoenwitthaya P
Arch Dermatol Res; 2017 Jul; 309(5):403-408. PubMed ID: 28303329
[TBL] [Abstract][Full Text] [Related]
5. [Evaluation of liver fibrosis by non-invasive methods].
Tor J; Muga R
Med Clin (Barc); 2011 Nov; 137(14):642-4. PubMed ID: 21752404
[No Abstract] [Full Text] [Related]
6. Association between cumulative methotrexate dose, non-invasive scoring system and hepatic fibrosis detected by Fibroscan in rheumatoid arthritis patients receiving methotrexate.
Lertnawapan R; Chonprasertsuk S; Siramolpiwat S
Int J Rheum Dis; 2019 Feb; 22(2):214-221. PubMed ID: 30565876
[TBL] [Abstract][Full Text] [Related]
7. Psoriasis, transient elastography and methotrexate: monitoring at a tertiary hospital.
Koch K
Australas J Dermatol; 2021 Feb; 62(1):69-70. PubMed ID: 32700316
[No Abstract] [Full Text] [Related]
8. Magnetic resonance elastography and transient elastography as non-invasive analyses for liver fibrosis: can they obviate the need for liver biopsy in psoriasis patients treated with methotrexate?
Kaffenberger BH; Kaffenberger JA; Wong H; Jarjour W; Levin D; Bechtel MA
Int J Dermatol; 2015 Jul; 54(7):752-6. PubMed ID: 26108262
[TBL] [Abstract][Full Text] [Related]
9. A pragmatic non-invasive assessment of liver fibrosis in patients with psoriasis, rheumatoid arthritis or Crohn's disease receiving methotrexate therapy.
Cervoni JP; Alby-Lepresle B; Weil D; Zhong P; Aubin F; Wendling D; Toussirot E; Vuitton L; Carbonnel F; Blondet R; Thévenot T; Calès P; Monnet E; Di Martino V
Clin Res Hepatol Gastroenterol; 2020; 44S():100003. PubMed ID: 33602481
[TBL] [Abstract][Full Text] [Related]
10. Compensated heart failure does not always alleviate overestimation of liver stiffness by transient elastography.
Park Y; Kim SU; Koh MJ; Lee S
Eur J Gastroenterol Hepatol; 2013 Mar; 25(3):385-7. PubMed ID: 23348020
[No Abstract] [Full Text] [Related]
11. Psoriasis and liver fibrosis: an investigation using transient elastography in Tunisian patients with psoriasis.
Ben Lagha I; Jaber K; Rabhi F; Slimane BB; Mrabet A; Abdelli N; Dhaoui MR
Br J Dermatol; 2019 Dec; 181(6):1306-1308. PubMed ID: 31145808
[No Abstract] [Full Text] [Related]
12. Practice gaps. Methotrexate-induced liver toxicity: replacing the liver biopsy.
Strober BE
JAMA Dermatol; 2014 Aug; 150(8):862-3. PubMed ID: 24965863
[No Abstract] [Full Text] [Related]
13. Methotrexate induced liver disease in psoriasis.
Millward-Sadler GH; Ryan TJ
Br J Dermatol; 1974 Jun; 90(6):661-7. PubMed ID: 4853200
[No Abstract] [Full Text] [Related]
14. Analysis of risk factors in psoriatic patients with methotrexate-induced increases in transaminase levels.
Heydendael VM; Spuls PI; Bossuyt PM; Bos JD; de Rie MA
Arch Dermatol; 2004 Oct; 140(10):1289-90. PubMed ID: 15492205
[No Abstract] [Full Text] [Related]
15. Detection of hepatotoxicity associated with methotrexate therapy for psoriasis.
O'Connor GT; Olmstead EM; Zug K; Baughman RD; Beck JR; Dunn JL; Seal P; Lewandowski JF
Arch Dermatol; 1989 Sep; 125(9):1209-17. PubMed ID: 2774596
[TBL] [Abstract][Full Text] [Related]
16. Dynamic hepatic scintigraphy in the screening of psoriatic patients for methotrexate-induced hepatotoxicity.
McHenry PM; Bingham EA; Callender ME; Delvin PB; O'Hara MD; Ferguson WR; Laird JD; Burrows D
Br J Dermatol; 1992 Aug; 127(2):122-5. PubMed ID: 1390139
[TBL] [Abstract][Full Text] [Related]
17. Liver fibrosis screening for patients with psoriasis taking methotrexate: a cross-sectional study comparing transient elastography and liver biopsy.
Bray AP; Barnova I; Przemioslo R; Kennedy CT
Br J Dermatol; 2012 May; 166(5):1125-7. PubMed ID: 21967341
[No Abstract] [Full Text] [Related]
18. Evaluation of liver fibrosis by transient elastography (Fibroscan®) in patients with inflammatory bowel disease treated with methotrexate: a multicentric trial.
Barbero-Villares A; Mendoza Jiménez-Ridruejo J; Taxonera C; López-Sanromán A; Pajares R; Bermejo F; Pérez-Calle JL; Mendoza JL; Algaba A; Moreno-Otero R; Maté J; Gisbert JP;
Scand J Gastroenterol; 2012 May; 47(5):575-9. PubMed ID: 22229701
[TBL] [Abstract][Full Text] [Related]
19. Liver injury associated with methotrexate therapy for psoriasis.
Podurgiel BJ; McGill DB; Ludwig J; Taylor WF; Muller SA
Mayo Clin Proc; 1973 Nov; 48(11):787-92. PubMed ID: 4758150
[No Abstract] [Full Text] [Related]
20. Validity of noninvasive markers of methotrexate-induced hepatotoxicity: a retrospective cohort study.
Martyn-Simmons CL; Rosenberg WM; Cross R; Wong T; Smith CH; Barker JN
Br J Dermatol; 2014 Aug; 171(2):267-73. PubMed ID: 24942271
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
